# FDA Inspection 1087618 - Regenerative Biologics, Inc. - March 28, 2019

Source: https://www.globalkeysolutions.net/records/fda_inspections/regenerative-biologics-inc/fc6c26fe-649b-40e2-9a9e-6257fb755343/
Source feed: FDA_Inspections

> FDA Inspection 1087618 for Regenerative Biologics, Inc. on March 28, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1087618
- Company Name: Regenerative Biologics, Inc.
- Inspection Date: 2019-03-28
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1087618 - 2019-03-28](https://www.globalkeysolutions.net/api/records/fda_inspections/regenerative-biologics-inc/de13452a-69c6-4ff0-94f7-629dcc9a4fab/)
- [FDA Inspection 1020143 - 2017-06-12](https://www.globalkeysolutions.net/api/records/fda_inspections/regenerative-biologics-inc/4e8471b6-fe6f-4bf4-814e-8eea39b314e3/)
- [FDA Inspection 730961 - 2011-06-20](https://www.globalkeysolutions.net/api/records/fda_inspections/regenerative-biologics-inc/4551ec30-1ac3-4e61-8e2c-4776483681b7/)

Company: https://www.globalkeysolutions.net/companies/regenerative-biologics-inc/ccf239ce-7605-4d9b-8b9c-944807ef010f

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d